Effect of tablet splitting on serum cholesterol concentrations

Annals of Pharmacotherapy

Volumn 36, Issue 2, 2002, Pages 205-209

  Duncan, Megan C ^a,b   Castle, Sharon S ^a   Streetman, Daniel S ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Centra Health   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Atorvastatin; LDL cholesterol; Simvastatin; Tablet splitting; Total cholesterol

Indexed keywords

ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TABLET; TREATMENT OUTCOME;

CHOLESTEROL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DRUG COSTS; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; RETROSPECTIVE STUDIES; SIMVASTATIN; TABLETS; WEST VIRGINIA;

EID: 0036159125     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A233     Document Type: Article

References (13)

1. Evaluation of tablet-splitting in patients taking lisinopril for hypertension
2. Accuracy of tablet splitting
3. Patient response to tablet splitting in a Veterans Affairs Medical Center (RP-89)
4. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients
5. A practical approach to the laboratory diagnosis of dyslipidemia
6. Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification
7. Dose-response characteristics of cholesterol-lowering drug therapies: Implications for treatment
8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
9. Helsinki heart study
10. Pharmacoeconomic assessment of HMG-CoA reductase inhibitor therapy: An analysis based on the CURVES Study
11. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
12. The tablet splitter: Barrier to compliance or cost-saving instrument?
13. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance